Chesapeake Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $55.6K | Hold |
917
| – | – | 0.04% | 146 |
|
|
2025
Q4 | $49.5K | Hold |
917
| – | – | 0.04% | 155 |
|
|
2025
Q3 | $41.4K | Hold |
917
| – | – | 0.04% | 148 |
|
|
2025
Q2 | $42.4K | Sell |
917
-15
| -2% | -$736 | 0.04% | 141 |
|
|
2025
Q1 | $56.8K | Hold |
932
| – | – | 0.05% | 118 |
|
|
2024
Q4 | $52.7K | Hold |
932
| – | – | 0.05% | 127 |
|
|
2024
Q3 | $48.2K | Buy |
932
+15
| +2% | +$704 | 0.04% | 131 |
|
|
2024
Q2 | $38.1K | Hold |
917
| – | – | 0.04% | 138 |
|
|
2024
Q1 | $49.7K | Sell |
917
-75
| -8% | -$3.82K | 0.05% | 121 |
|
|
2023
Q4 | $50.9K | Buy |
992
+1
| +0.1% | +$52 | 0.05% | 136 |
|
|
2023
Q3 | $57.5K | Sell |
991
-1,999
| -67% | -$122K | 0.06% | 133 |
|
|
2023
Q2 | $191K | Sell |
2,990
-1,260
| -30% | -$84.5K | 0.17% | 89 |
|
|
2023
Q1 | $295K | Buy |
+4,250
| New | +$300K | 0.27% | 74 |
|
|
2019
Q4 | $1.71M | Buy |
+26,670
| New | +$1.53M | 2.9% | 13 |
|
|
2018
Q4 | – | Sell |
-3,711
| Closed | -$230K | – | 40 |
|
|
2018
Q3 | $230K | Sell |
3,711
-100
| -3% | -$5.93K | 0.26% | 56 |
|
|
2018
Q2 | $211K | Sell |
3,811
-80
| -2% | -$4.32K | 0.25% | 58 |
|
|
2018
Q1 | $246K | Sell |
3,891
-80
| -2% | -$5.15K | 0.26% | 59 |
|
|
2017
Q4 | $243K | Hold |
3,971
| – | – | 0.23% | 62 |
|
|
2017
Q3 | $253K | Hold |
3,971
| – | – | 0.23% | 62 |
|
|
2017
Q2 | $221K | Sell |
3,971
-667
| -14% | -$36.3K | 0.21% | 60 |
|
|
2017
Q1 | $252K | Sell |
4,638
-80
| -2% | -$4.39K | 0.21% | 73 |
|
|
2016
Q4 | $276K | Hold |
4,718
| – | – | 0.24% | 63 |
|
|
2016
Q3 | $254K | Hold |
4,718
| – | – | 0.23% | 66 |
|
|
2016
Q2 | $347K | Hold |
4,718
| – | – | 0.28% | 63 |
|
|
2016
Q1 | $301K | Hold |
4,718
| – | – | 0.25% | 54 |
|
|
2015
Q4 | $325K | Hold |
4,718
| – | – | 0.25% | 59 |
|
|
2015
Q3 | $279K | Sell |
4,718
-120
| -2% | -$7.61K | 0.24% | 57 |
|
|
2015
Q2 | $322K | Hold |
4,838
| – | – | 0.24% | 57 |
|
|
2015
Q1 | $312K | Hold |
4,838
| – | – | 0.23% | 58 |
|
|
2014
Q4 | $286K | Hold |
4,838
| – | – | 0.18% | 76 |
|
|
2014
Q3 | $248K | Buy |
4,838
+200
| +4% | +$9.99K | 0.15% | 72 |
|
|
2014
Q2 | $225K | Sell |
4,638
-200
| -4% | -$9.86K | 0.14% | 75 |
|
|
2014
Q1 | $251K | Hold |
4,838
| – | – | 0.17% | 69 |
|
|
2013
Q4 | $257K | Hold |
4,838
| – | – | 0.15% | 71 |
|
|
2013
Q3 | $224K | Hold |
4,838
| – | – | 0.15% | 73 |
|
|
2013
Q2 | $216K | Buy |
+4,838
| New | +$210K | 0.16% | 70 |
|
Other funds holding BMY
VCM
VPM
Chesapeake Asset Management's BMY Position: Q1 2026 in Review
Chesapeake Asset Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 917 shares worth $55.6K. The position accounts for 0.04% of the portfolio, ranked #146.
Chesapeake Asset Management first reported a position in BMY in Q2 2013 and has held it in 36 quarters since. The position peaked at $1.71M in Q4 2019. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Chesapeake Asset Management held 917 shares of Bristol-Myers Squibb worth $55.6K as of Q1 2026.
- Chesapeake Asset Management left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 0.04% of Chesapeake Asset Management's portfolio in Q1 2026, its #146 holding.
- Chesapeake Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 36 quarters since.
- Chesapeake Asset Management's Bristol-Myers Squibb position peaked at $1.71M in Q4 2019.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Chesapeake Asset Management's 13F filing for Q1 2026, filed 12 May 2026.